The immunological basis for treatment of stiff person syndrome

Journal of Neuroimmunology

Volumn 231, Issue 1-2, 2011, Pages 55-60

  Holmøy, Trygve ^a,b   Geis, Christian ^c  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Aurtoantibodies; Autoimmunity; Stiff person syndrome; T cells

Indexed keywords

4 AMINOBUTYRIC ACID; AMPHIPHYSIN; AUTOANTIBODY; AUTOANTIGEN; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; GLUTAMATE DECARBOXYLASE 67; PROTEIN ANTIBODY; RITUXIMAB;

ANTIBODY PRODUCTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DAMAGE; CELLULAR IMMUNITY; CEREBELLAR ATAXIA; DISEASE COURSE; GABAERGIC TRANSMISSION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; STIFF MAN SYNDROME; TH2 CELL;

EID: 79952442255     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.09.014     Document Type: Article

References (114)

1. Aktas O., Smorodchenko A., Brocke S., Infante-Duarte C., Schulze Topphoff U., Vogt J., Prozorovski T., Meier S., Osmanova V., Pohl E., Bechmann I., Nitsch R., Zipp F. Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL. Neuron 2005, 46:421-432.
2. Al-Bukhari T.A., Radford P.M., Bouras G., Davenport C., Trigwell S.M., Bottazzo G.F., Lai M., Schwartz H.L., Tighe P.J., Todd I. Distinct antigenic features of linear epitopes at the N-terminus and C-terminus of 65kDa glutamic acid decarboxylase (GAD65): implications for autoantigen modification during pathogenesis. Clin. Exp. Immunol. 2002, 130:131-139.
3. Armon C., Swanson J.W., McLean J.M., Westbrook P.R., Okazaki H., Kurtin P.J., Kalyan-Raman U.P., Rodriguez M. Subacute encephalomyelitis presenting as stiff-person syndrome: clinical, polygraphic, and pathologic correlations. Mov. Disord. 1996, 11:701-709.
4. Atkinson M.A., Bowman M.A., Campbell L., Darrow B.L., Kaufman D.L., Maclaren N.K. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J. Clin. Invest. 1994, 94:2125-2129.
5. Bacorro E.A., Tehrani R. Stiff-person syndrome: persistent elevation of glutamic acid decarboxylase antibodies despite successful treatment with rituximab. J. Clin. Rheumatol. 2010, 2010(16):237-239.
6. Baekkeskov S., Aanstoot H.J., Christgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., De Camilli P. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990, 347:151-156.
7. Baker M.R., Das M., Isaacs J., Fawcett P.R., Bates D. Treatment of stiff person syndrome with rituximab. J. Neurol. Neurosurg. Psychiatry 2005, 76:999-1001.
8. Banga J.P., Moore J.K., Duhindan N., Madec A.M., van Endert P.M., Orgiazzi J., Endl J. Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patient. Clin. Exp. Immunol. 2004, 135:74-84.
9. Barker R.A., Revesz T., Thom M., Marsden C.D., Brown P. Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J. Neurol. Neurosurg. Psychiatry 1998, 65:633-640.
10. Bennett J.L., Lam C., Kalluri S.R., Saikali P., Bautista K., Dupree C., Glogowska M., Case D., Antel J.P., Owens G.P., Gilden D., Nessler S., Stadelmann C., Hemmer B. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann. Neurol. 2009, 66:617-629.
11. Boettger M.K., Weishaupt A., Geis C., Toyka K.V., Sommer C. Mild experimental autoimmune encephalitis as a tool to induce blood-brain barrier dysfunction. J. Neural Transm. 2010, 117:165-169.
12. Borges L.F., Elliott P.J., Gill R., Iversen S.D., Iversen L.L. Selective extraction of small and large molecules from the cerebrospinal fluid by Purkinje neurons. Science 1985, 228:346-348.
13. Bradl M., Misu T., Takahashi T., Watanabe M., Mader S., Reindl M., Adzemovic M., Bauer J., Berger T., Fujihara K., Itoyama Y., Lassmann H. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann. Neurol. 2009, 66:630-643.
14. Brown P., Marsden C.D. The stiff man and stiff man plus syndromes. J. Neurol. 1999, 246:648-652.
15. Brown P., Rothwell J.C., Marsden C.D. The stiff leg syndrome. J. Neurol. Neurosurg. Psychiatry 1997, 62:31-37.
16. Burbelo P.D., Groot S., Dalakas M.C., Iadarola M.J. High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome. Biochem. Biophys. Res. Commun. 2008, 366:1-7.
17. Burton A.R., Baquet Z., Eisenbarth G.S., Tisch R., Smeyne R., Workman C.J., Vignali D.A. Central nervous system destruction mediated by glutamic acid decarboxylase-specific CD4(+) T cells. J. Immunol. 2010, 184:4863-4870.
18. Butler M.H., Solimena M., Dirkx R., Hayday A., De Camilli P. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J. Exp. Med. 1993, 178:2097-2106.
19. Butler M.H., Hayashi A., Ohkoshi N., Villmann C., Becker C.M., Feng G., De Camilli P., Solimena M. Autoimmunity to gephyrin in Stiff-Man syndrome. Neuron 2000, 26:307-312.
20. Cepok S., Rosche B., Grummel V., Vogel F., Zhou D., Sayn J., Sommer N., Hartung H.P., Hemmer B. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 2005, 128:1667-1676.
21. Costa M., Saiz A., Casamitjana R., Castaner M.F., Sanmarti A., Graus F., Jaraquemada D. T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity. Clin. Exp. Immunol. 2002, 129:471-478.
22. Dai Y.D., Sercarz E.E. Antigen processing patterns determine GAD65-specific regulation vs. pathogenesis. Front. Biosci. 2009, 14:344-351.
23. Dalakas M.C. Advances in the pathogenesis and treatment of patients with stiff person syndrome. Curr. Neurol. Neurosci. Rep. 2008, 8:48-55.
24. Dalakas M.C. Stiff person syndrome: advances in pathogenesis and therapeutic interventions. Curr. Treat. Options Neurol. 2009, 11:102-110.
25. Dalakas M.C., Fujii M., Li M., McElroy B. The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology 2000, 55:1531-1535.
26. Dalakas M.C., Fujii M., Li M., Lutfi B., Kyhos J., McElroy B. High-dose intravenous immune globulin for stiff-person syndrome. N Engl J. Med. 2001, 345:1870-1876.
27. Dalakas M.C., Li M., Fujii M., Jacobowitz D.M. Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies. Neurology 2001, 57:780-784.
28. David C., Solimena M., De Camilli P. Autoimmunity in stiff-Man syndrome with breast cancer is targeted to the C-terminal region of human amphiphysin, a protein similar to the yeast proteins, Rvs167 and Rvs161. FEBS Lett. 1994, 351:73-79.
29. Daw K., Ujihara N., Atkinson M., Powers A.C. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J. Immunol. 1996, 156:818-825.
30. De Camilli P., Thomas A., Cofiell R., Folli F., Lichte B., Piccolo G., Meinck H.M., Austoni M., Fassetta G., Bottazzo G., et al. The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer. J. Exp. Med. 1993, 178:2219-2223.
31. Di Paolo G., Sankaranarayanan S., Wenk M.R., Daniell L., Perucco E., Caldarone B.J., Flavell R., Picciotto M.R., Ryan T.A., Cremona O., De Camilli P. Decreased synaptic vesicle recycling efficiency and cognitive deficits in amphiphysin 1 knockout mice. Neuron 2002, 33:789-804.
32. Dinkel K., Meinck H.M., Jury K.M., Karges W., Richter W. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann. Neurol. 1998, 44:194-201.
33. Ferguson S.M., Brasnjo G., Hayashi M., Wolfel M., Collesi C., Giovedi S., Raimondi A., Gong L.W., Ariel P., Paradise S., O'Toole E., Flavell R., Cremona O., Miesenbock G., Ryan T.A., De Camilli P. A selective activity-dependent requirement for dynamin 1 in synaptic vesicle endocytosis. Science 2007, 316:570-574.
34. Floeter M.K., Valls-Sole J., Toro C., Jacobowitz D., Hallett M. Physiologic studies of spinal inhibitory circuits in patients with stiff-person syndrome. Neurology 1998, 51:85-93.
35. Floyd S., Butler M.H., Cremona O., David C., Freyberg Z., Zhang X., Solimena M., Tokunaga A., Ishizu H., Tsutsui K., De Camilli P. Expression of amphiphysin I, an autoantigen of paraneoplastic neurological syndromes, in breast cancer. Mol. Med. 1998, 4:29-39.
36. Garzon J., DeFelipe J., Rodriguez J.R., DeAntonio I., Garcia-Espana A., Sanchez-Blazquez P. Transport of CSF antibodies to Galpha subunits across neural membranes requires binding to the target protein and protein kinase C activity. Brain Res. Mol. Brain Res. 1999, 65:151-166.
37. Geis C., Beck M., Jablonka S., Weishaupt A., Toyka K.V., Sendtner M., Sommer C. Stiff person syndrome associated anti-amphiphysin antibodies reduce GABA associated [Ca(2+)]i rise in embryonic motoneurons. Neurobiol. Dis. 2009, 36:191-199.
38. Giuliani F., Goodyer C.G., Antel J.P., Yong V.W. Vulnerability of human neurons to T cell-mediated cytotoxicity. J. Immunol. 2003, 171:368-379.
39. Hänninen A., Soilu-Hänninen M., Hampe C.S., Deptula A., Geubtner K., Ilonen J., Knip M., Reijonen H. Characterization of CD4+ T cells specific for glutamic acid decarboxylase (GAD65) and proinsulin in a patient with stiff-person syndrome but without type 1 diabetes. Diab. Metab. Res. Rev. 2010, 26:271-279.
40. Hassin-Baer S., Kirson E.D., Shulman L., Buchman A.S., Bin H., Hindiyeh M., Markevich L., Mendelson E. Stiff-person syndrome following West Nile fever. Arch. Neurol. 2004, 61:938-941.
41. Henningsen P., Clement U., Kuchenhoff J., Simon F., Meinck H.M. Psychological factors in the diagnosis and pathogenesis of stiff-man syndrome. Neurology 1996, 47:38-42.
42. Hestvik A.L., Skorstad G., Price D.A., Vartdal F., Holmoy T. Multiple sclerosis: glatiramer acetate induces anti-inflammatory T cells in the cerebrospinal fluid. Mult. Scler. 2008, 14:749-758.
43. Hestvik A.L., Skorstad G., Vartdal F., Holmoy T. Idiotope-specific CD4(+) T cells induce apoptosis of human oligodendrocytes. J. Autoimmun. 2009, 32:125-132.
44. Hiemstra H.S., Schloot N.C., van Veelen P.A., Willemen S.J., Franken K.L., van Rood J.J., de Vries R.R., Chaudhuri A., Behan P.O., Drijfhout J.W., Roep B.O. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc. Natl Acad. Sci. USA 2001, 98:3988-3991.
45. Hill K.E., Clawson S.A., Rose J.W., Carlson N.G., Greenlee J.E. Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics. J. Neuroinflammation 2009, 6:31.
46. Holmoy T., Skorstad G., Roste L.S., Scheie D., Alvik K. Stiff person syndrome associated with lower motor neuron disease and infiltration of cytotoxic T cells in the spinal cord. Clin. Neurol. Neurosurg. 2009, 111:708-712.
47. Honnorat J., Saiz A., Giometto B., Vincent A., Brieva L., de Andres C., Maestre J., Fabien N., Vighetto A., Casamitjana R., Thivolet C., Tavolato B., Antoine J., Trouillas P., Graus F. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch. Neurol. 2001, 58:225-230.
48. Hoyer B.F., Moser K., Hauser A.E., Peddinghaus A., Voigt C., Eilat D., Radbruch A., Hiepe F., Manz R.A. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J. Exp. Med. 2004, 199:1577-1584.
49. Hummel M., Durinovic-Bello I., Bonifacio E., Lampasona V., Endl J., Fessele S., Then Bergh F., Trenkwalder C., Standl E., Ziegler A.G. Humoral and cellular immune parameters before and during immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus. J. Neurol. Neurosurg. Psychiatry 1998, 65:204-208.
50. Ishida K., Mitoma H., Song S.Y., Uchihara T., Inaba A., Eguchi S., Kobayashi T., Mizusawa H. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann. Neurol. 1999, 46:263-267.
51. Ishida K., Mitoma H., Mizusawa H. Reversibility of cerebellar GABAergic synapse impairment induced by anti-glutamic acid decarboxylase autoantibodies. J. Neurol. Sci. 2008, 271:186-190.
52. Itoh T., De Camilli P. BAR, F-BAR (EFC) and ENTH/ANTH domains in the regulation of membrane-cytosol interfaces and membrane curvature. Biochim. Biophys. Acta 2006, 1761:897-912.
53. Jabri B., Sollid L.M. Tissue-mediated control of immunopathology in coeliac disease. Nat. Rev. Immunol. 2009, 9:858-870.
54. Jaume J.C., Parry S.L., Madec A.M., Sonderstrup G., Baekkeskov S. Suppressive effect of glutamic acid decarboxylase 65-specific autoimmune B lymphocytes on processing of T cell determinants located within the antibody epitope. J. Immunol. 2002, 169:665-672.
55. Jin H., Wu H., Osterhaus G., Wei J., Davis K., Sha D., Floor E., Hsu C.C., Kopke R.D., Wu J.Y. Demonstration of functional coupling between gamma-aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles. Proc. Natl Acad. Sci. USA 2003, 100:4293-4298.
56. Kasperek S., Zebrowski S. Stiff-man syndrome and encephalomyelitis. Report of a case. Arch. Neurol. 1971, 24:22-30.
57. Katoh N., Matsuda M., Ishii W., Morita H., Ikeda S. Successful treatment with rituximab in a patient with stiff-person syndrome complicated by dysthyroid ophthalmopathy. Intern. Med. 2010, 49:237-241.
58. Kim J., Namchuk M., Bugawan T., Fu Q., Jaffe M., Shi Y., Aanstoot H.J., Turck C.W., Erlich H., Lennon V., Baekkeskov S. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J. Exp. Med. 1994, 180:595-606.
59. Kittler J.T., Delmas P., Jovanovic J.N., Brown D.A., Smart T.G., Moss S.J. Constitutive endocytosis of GABAA receptors by an association with the adaptin AP2 complex modulates inhibitory synaptic currents in hippocampal neurons. J. Neurosci. 2000, 20:7972-7977.
60. Leigh P.N., Rothwell J.C., Traub M., Marsden C.D. A patient with reflex myoclonus and muscle rigidity: "jerking stiff-man syndrome". J. Neurol. Neurosurg. Psychiatry 1980, 43:1125-1131.
61. Lohmann T., Hawa M., Leslie R.D., Lane R., Picard J., Londei M. Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus. Lancet 2000, 356:31-35.
62. Lohmann T., Londei M., Hawa M., Leslie R.D. Humoral and cellular autoimmune responses in stiff person syndrome. Ann. NY Acad. Sci. 2003, 998:215-222.
63. Ludvigsson J., Faresjo M., Hjorth M., Axelsson S., Cheramy M., Pihl M., Vaarala O., Forsander G., Ivarsson S., Johansson C., Lindh A., Nilsson N.O., Aman J., Ortqvist E., Zerhouni P., Casas R. GAD treatment and insulin secretion in recent-onset type 1 diabetes. N Engl J. Med. 2008, 359:1909-1920.
64. Malter M.P., Helmstaedter C., Urbach H., Vincent A., Bien C.G. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann. Neurol. 2010, 67:470-478.
65. Manto M.U., Laute M.A., Aguera M., Rogemond V., Pandolfo M., Honnorat J. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann. Neurol. 2007, 61:544-551.
66. Marsh M., McMahon H.T. The structural era of endocytosis. Science 1999, 285:215-220.
67. Martens H., Weston M.C., Boulland J.L., Gronborg M., Grosche J., Kacza J., Hoffmann A., Matteoli M., Takamori S., Harkany T., Chaudhry F.A., Rosenmund C., Erck C., Jahn R., Hartig W. Unique luminal localization of VGAT-C terminus allows for selective labeling of active cortical GABAergic synapses. J. Neurosci. 2008, 28:13125-13131.
68. Martinelli P., Pazzaglia P., Montagna P., Coccagna G., Rizzuto N., Simonati S., Lugaresi E. Stiff-man syndrome associated with nocturnal myoclonus and epilepsy. J. Neurol. Neurosurg. Psychiatry 1978, 41:458-462.
69. Matyszak M.K., Denis-Donini S., Citterio S., Longhi R., Granucci F., Ricciardi-Castagnoli P. Microglia induce myelin basic protein-specific T cell anergy or T cell activation, according to their state of activation. Eur. J. Immunol. 1999, 29:3063-3076.
70. McKnight K., Jiang Y., Hart Y., Cavey A., Wroe S., Blank M., Shoenfeld Y., Vincent A., Palace J., Lang B. Serum antibodies in epilepsy and seizure-associated disorders. Neurology 2005, 65:1730-1736.
71. Meinck H.M., Ricker K., Hulser P.J., Schmid E., Peiffer J., Solimena M. Stiff man syndrome: clinical and laboratory findings in eight patients. J. Neurol. 1994, 241:157-166.
72. Meinl E., Krumbholz M., Hohlfeld R. B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation. Ann. Neurol. 2006, 59:880-892.
73. Mitoma H., Song S.Y., Ishida K., Yamakuni T., Kobayashi T., Mizusawa H. Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase. J. Neurol. Sci. 2000, 175:40-44.
74. Mitoma H., Ishida K., Shizuka-Ikeda M., Mizusawa H. Dual impairment of GABAA- and GABAB-receptor-mediated synaptic responses by autoantibodies to glutamic acid decarboxylase. J. Neurol. Sci. 2003, 208:51-56.
75. Mitsumoto H., Schwartzman M.J., Estes M.L., Chou S.M., La Franchise E.F., De Camilli P., Solimena M. Sudden death and paroxysmal autonomic dysfunction in stiff-man syndrome. J. Neurol. 1991, 238:91-96.
76. Moersch F.P., Woltman H.W. Progressive fluctuating muscular rigidity and spasm ("stiff-man" syndrome); report of a case and some observations in 13 other cases. Proc. Staff Meet. Mayo Clin. 1956, 31:421-427.
77. Mohamed H.A., Mosier D.R., Zou L.L., Siklos L., Alexianu M.E., Engelhardt J.I., Beers D.R., Le W.D., Appel S.H. Immunoglobulin Fc gamma receptor promotes immunoglobulin uptake, immunoglobulin-mediated calcium increase, and neurotransmitter release in motor neurons. J. Neurosci. Res. 2002, 69:110-116.
78. Murinson B.B., Guarnaccia J.B. Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease. Neurology 2008, 71:1955-1958.
79. Nakamura N., Fujiya S., Yahara O., Fujioka Y., Kawakami Y. Stiff-man syndrome with spinal cord lesion. Clin. Neuropathol. 1986, 5:40-46.
80. Neumann H. Control of glial immune function by neurons. Glia 2001, 36:191-199.
81. Nitsch R., Pohl E.E., Smorodchenko A., Infante-Duarte C., Aktas O., Zipp F. Direct impact of T cells on neurons revealed by two-photon microscopy in living brain tissue. J. Neurosci. 2004, 24:2458-2464.
82. Oak S., Gilliam L.K., Landin-Olsson M., Torn C., Kockum I., Pennington C.R., Rowley M.J., Christie M.R., Banga J.P., Hampe C.S. The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes. Proc. Natl Acad. Sci. USA 2008, 105:5471-5476.
83. Ochsenbein A.F., Pinschewer D.D., Sierro S., Horvath E., Hengartner H., Zinkernagel R.M. Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs. Proc. Natl Acad. Sci. USA 2000, 97:13263-13268.
84. Pittock S.J., Lucchinetti C.F., Parisi J.E., Benarroch E.E., Mokri B., Stephan C.L., Kim K.K., Kilimann M.W., Lennon V.A. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann. Neurol. 2005, 58:96-107.
85. Pugliese A., Solimena M., Awdeh Z.L., Alper C.A., Bugawan T., Erlich H.A., De Camilli P., Eisenbarth G.S. Association of HLA-DQB1*0201 with stiff-man syndrome. J. Clin. Endocrinol. Metab. 1993, 77:1550-1553.
86. Pugliese A., Gianani R., Eisenbarth G.S., De Camilli P., Solimena M. Genetics of susceptibility and resistance to insulin-dependent diabetes in stiff-man syndrome. Lancet 1994, 344:1027-1028.
87. Raju R., Hampe C.S. Immunobiology of stiff-person syndrome. Int. Rev. Immunol. 2008, 27:79-92.
88. Raju R., Foote J., Banga J.P., Hall T.R., Padoa C.J., Dalakas M.C., Ortqvist E., Hampe C.S. Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients. J. Immunol. 2005, 175:7755-7762.
89. Raju R., Rakocevic G., Chen Z., Hoehn G., Semino-Mora C., Shi W., Olsen R., Dalakas M.C. Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome. Brain 2006, 129:3270-3276.
90. Reijonen H., Daniels T.L., Lernmark A., Nepom G.T. GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65. Diabetes 2000, 49:1621-1626.
91. Rizzi M., Knoth R., Hampe C.S., Lorenz P., Gougeon M.L., Lemercier B., Venhoff N., Ferrera F., Salzer U., Thiesen H.J., Peter H.H., Walker U.A., Eibel H. Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff person syndrome. PLoS ONE 2010, 26(5):e10838.
92. Saadoun S., Waters P., Bell B.A., Vincent A., Verkman A.S., Papadopoulos M.C. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 2010, 133:349-361.
93. Saiz A., Blanco Y., Sabater L., Gonzalez F., Bataller L., Casamitjana R., Ramio-Torrenta L., Graus F. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008, 131:2553-2563.
94. Schloot N.C., Batstra M.C., Duinkerken G., De Vries R.R., Dyrberg T., Chaudhuri A., Behan P.O., Roep B.O. GAD65-reactive T cells in a non-diabetic stiff-man syndrome patient. J. Autoimmun. 1999, 12:289-296.
95. Shupliakov O., Low P., Grabs D., Gad H., Chen H., David C., Takei K., De Camilli P., Brodin L. Synaptic vesicle endocytosis impaired by disruption of dynamin-SH3 domain interactions. Science 1997, 276:259-263.
96. Skorstad G., Hestvik A.L., Torjesen P., Alvik K., Vartdal F., Vandvik B., Holmoy T. GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence. Eur. J. Neurol. 2008, 15:973-980.
97. Skorstad G., Hestvik A.L., Vartdal F., Holmoy T. Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome. J. Autoimmun. 2009, 32:24-32.
98. Solimena M., Folli F., Denis-Donini S., Comi G.C., Pozza G., De Camilli P., Vicari A.M. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J. Med. 1988, 318:1012-1020.
99. Solimena M., Folli F., Aparisi R., Pozza G., De Camilli P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J. Med. 1990, 322:1555-1560.
100. Sommer C., Weishaupt A., Brinkhoff J., Biko L., Wessig C., Gold R., Toyka K.V. Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin. Lancet 2005, 365:1406-1411.
101. Stich O., Jarius S., Kleer B., Rasiah C., Voltz R., Rauer S. Specific antibody index in cerebrospinal fluid from patients with central and peripheral paraneoplastic neurological syndromes. J. Neuroimmunol. 2007, 183:220-224.
102. Takenoshita H., Shizuka-Ikeda M., Mitoma H., Song S., Harigaya Y., Igeta Y., Yaguchi M., Ishida K., Shoji M., Tanaka M., Mizusawa H., Okamoto K. Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia. J. Neurol. Neurosurg. Psychiatry 2001, 70:386-389.
103. Tian N., Petersen C., Kash S., Baekkeskov S., Copenhagen D., Nicoll R. The role of the synthetic enzyme GAD65 in the control of neuronal gamma-aminobutyric acid release. Proc. Natl Acad. Sci. USA 1999, 96:12911-12916.
104. Torkildsen O., Stansberg C., Angelskar S.M., Kooi E.J., Geurts J.J., van der Valk P., Myhr K.M., Steen V.M., Bo L. Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. Brain Pathol. 2009, 20:720-729.
105. Tuomi T., Rowley M.J., Knowles W.J., Chen Q.Y., McAnally T., Zimmet P.Z., Mackay I.R. Autoantigenic properties of native and denatured glutamic acid decarboxylase: evidence for a conformational epitope. Clin. Immunol. Immunopathol. 1994, 71:53-59.
106. Venhoff N., Rizzi M., Salzer U., Bossaller L., Thoden J., Eibel H., Walker U.A. Monozygotic twins with stiff person syndrome and autoimmune thyroiditis: rituximab inefficacy in a double-blind, randomised, placebo controlled crossover study. Ann. Rheum. Dis. 2009, 68:1506-1508.
107. Wang W.Z., Olsson T., Kostulas V., Hojeberg B., Ekre H.P., Link H. Myelin antigen reactive T cells in cerebrovascular diseases. Clin. Exp. Immunol. 1992, 88:157-162.
108. Warich-Kirches M., Von Bossanyi P., Treuheit T., Kirches E., Dietzmann K., Feistner H., Wittig H. Stiff-man syndrome: possible autoimmune etiology targeted against GABA-ergic cells. Clin. Neuropathol. 1997, 16:214-219.
109. Warren J.D., Scott G., Blumbergs P.C., Thompson P.D. Pathological evidence of encephalomyelitis in the stiff man syndrome with anti-GAD antibodies. J. Clin. Neurosci. 2002, 9:328-329.
110. Wessig C., Klein R., Schneider M.F., Toyka K.V., Naumann M., Sommer C. Neuropathology and binding studies in anti-amphiphysin-associated stiff-person syndrome. Neurology 2003, 61:195-198.
111. Whiteley A.M., Swash M., Urich H. Progressive encephalomyelitis with rigidity. Brain 1976, 99:27-42.
112. Winges K.M., Gilden D.H., Bennett J.L., Yu X., Ritchie A.M., Owens G.P. Analysis of multiple sclerosis cerebrospinal fluid reveals a continuum of clonally related antibody-secreting cells that are predominantly plasma blasts. J. Neuroimmunol. 2007, 192:226-234.
113. Wu Y., Matsui H., Tomizawa K. Amphiphysin I and regulation of synaptic vesicle endocytosis. Acta Med. Okayama 2009, 63:305-323.
114. Yoshimi K., Woo M., Son Y., Baudry M., Thompson R.F. IgG-immunostaining in the intact rabbit brain: variable but significant staining of hippocampal and cerebellar neurons with anti-IgG. Brain Res. 2002, 956:53-66.